Decreasing complexity of glucose time series derived from continuous glucose monitoring is correlated with deteriorating glucose regulation

Abstract

Most information used to evaluate diabetic statuses is collected at a special time-point, such as taking fasting plasma glucose test and providing a limited view of individual’s health and disease risk. As a new parameter for continuously evaluating personal clinical statuses, the newly developed technique “continuous glucose monitoring” (CGM) can characterize glucose dynamics. By calculating the complexity of glucose time series index (CGI) with refined composite multi-scale entropy analysis of the CGM data, the study showed for the first time that the complexity of glucose time series in subjects decreased gradually from normal glucose tolerance to impaired glucose regulation and then to type 2 diabetes (P for trend < 0.01). Furthermore, CGI was significantly associated with various parameters such as insulin sensitivity/secretion (all P < 0.01), and multiple linear stepwise regression showed that the disposition index, which reflects β-cell function after adjusting for insulin sensitivity, was the only independent factor correlated with CGI (P < 0.01). Our findings indicate that the CGI derived from the CGM data may serve as a novel marker to evaluate glucose homeostasis.

Keywords

complexity of glucose time series / continuous glucose monitoring / impaired glucose regulation / insulin secretion and sensitivity / refined composite multi-scale entropy

References

[1] Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X, Yang L, Zhao Z; Chinese Diabetes Society. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev 2019; 35(6): e3158

[2] Lu J, Ma X, Zhou J, Zhang L, Mo Y, Ying L, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 2018; 41(11): 2370–2376

[3] Lu J, Ma X, Shen Y, Wu Q, Wang R, Zhang L, Mo Y, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W, Zhou J. Time in range is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Technol Ther 2020; 22(2): 72–78

[4] Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol 2019; 7(3): 221–230

[5] Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International consensus on use of continuous glucose monitoring. Diabetes Care 2017; 40(12): 1631–1640

[6] Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42(8): 1593–1603

[7] Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther 2018; 20(S2): S25–S215, S2–15

[8] Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis. Int J Numer Methods Eng 2004; 59(9): 1147–1166

[9] Costa MD, Henriques T, Munshi MN, Segal AR, Goldberger AL. Dynamical glucometry: use of multiscale entropy analysis in diabetes. Chaos 2014; 24(3): 033139

[10] Chen JL, Chen PF, Wang HM. Decreased complexity of glucose dynamics in diabetes: evidence from multiscale entropy analysis of continuous glucose monitoring system data. Am J Physiol Regul Integr Comp Physiol 2014; 307(2): R179–R183

[11] Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379(9833): 2279–2290

[12] Acciaroli G, Sparacino G, Hakaste L, Facchinetti A, Di Nunzio GM, Palombit A, Tuomi T, Gabriel R, Aranda J, Vega S, Cobelli C. Diabetes and prediabetes classification using glycemic variability indices from continuous glucose monitoring data. J Diabetes Sci Technol 2018; 12(1): 105–113

[13] Chakarova N, Dimova R, Grozeva G, Tankova T. Assessment of glucose variability in subjects with prediabetes. Diabetes Res Clin Pract 2019; 151: 56–64

[14] Wang C, Lv L, Yang Y, Chen D, Liu G, Chen L, Song Y, He L, Li X, Tian H, Jia W, Ran X. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2012; 76(6): 810–815

[15] Li C, Ma X, Yin J, Mo Y, Zhang L, Lu J, Lu W, Bao Y, Vigersky RA, Zhou J, Jia W. The dawn phenomenon across the glycemic continuum: implications for defining dysglycemia. Diabetes Res Clin Pract 2020; 166: 108308

[16] Wu SD, Wu CW, Lin SG, Lee KY, Peng CK. Analysis of complex time series using refined composite multiscale entropy. Phys Lett A 2014; 378(20): 1369–1374

[17] Zhou J, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care 2009; 32(7): 1188–1193

[18] Zhou J, Mo Y, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Xie Y, Jia W. Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter study. PLoS One 2013; 8(12): e83827

[19] American Diabetes Association. Standards of medical care in diabetes−2007. Diabetes Care 2007; 30(Suppl 1): S4–S41

[20] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412–419

[21] Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10(2): 167–175

[22] Li C, Yang H, Tong G, Shen S, Feng W, Bi Y, Zhu D. Correlations between A1c, fasting glucose, 2 h postload glucose, and β-cell function in the Chinese population. Acta Diabetol 2014; 51(4): 601–608

[23] Kohnert KD, Heinke P, Vogt L, Augstein P, Thomas A, Salzsieder E. Associations of blood glucose dynamics with antihyperglycemic treatment and glycemic variability in type 1 and type 2 diabetes. J Endocrinol Invest 2017; 40(11): 1201–1207

[24] Lai Y, Zhang Z, Li P, Liu X, Liu Y, Xin Y, Gu W. Investigation of glucose fluctuations by approaches of multi-scale analysis. Med Biol Eng Comput 2018; 56(3): 505–514

[25] Kohnert KD, Heinke P, Vogt L, Augstein P, Salzsieder E. Applications of variability analysis techniques for continuous glucose monitoring derived time series in diabetic patients. Front Physiol 2018; 9: 1257

[26] Zhang XD, Pechter D, Yang L, Ping X, Yao Z, Zhang R, Shen X, Li NX, Connick J, Nawrocki AR, Chakravarthy M, Li C. Decreased complexity of glucose dynamics preceding the onset of diabetes in mice and rats. PLoS One 2017; 12(9): e0182810

[27] Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51(Suppl 1): S212–S220

[28] Li L, Sun J, Ruan L, Song Q. Time-series analysis of continuous glucose monitoring data to predict treatment efficacy in patients with T2DM. J Clin Endocrinol Metab 2021; 106(8): 2187–2197

RIGHTS & PERMISSIONS

Higher Education Press